Thus the search is on is to
discover additional cancer - causing genes «downstream» of TET mutations that drive uncontrolled cell division in either context.
Not exact matches
HOUSTON, April 20, 2018 (GLOBE NEWSWIRE)-- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) a clinical stage biopharmaceutical company focused on
discovering and developing cellular immunotherapies for
cancers and orphan inherited blood disorders, today announced the closing of its previously announced underwritten public offering of 9,200,000 shares of its common stock, including 1,200,000 shares sold pursuant to the underwriters» full exercise of their option to purchase
additional shares, at a public offering price of $ 7.50 per share.
«GECCO aims to continue to
discover additional colorectal
cancer - related variants by investigating how genetic variants are modified by other environmental and lifestyle risk factors, including biomarkers as well as how they influence patient treatment response and survival,» Peters said, emphasizing how much further research is required to uncover the specific mechanisms by which genes modulate the intake of certain foods on colorectal
cancer risk.
We can envision that DAXX can serve as a precise prognostic marker in PCa and that tissue - specific shRNA delivery targeted against DAXX can be employed in the treatment of metastatic prostate
cancer in patients, in particular if we
discover, through
additional studies, that DAXX is a marker for lethal PCa in humans.
Understanding the genetic makeup of canine
cancer tumors, and comparing their genetic makeup to those of people with
cancer, will allow researchers to
discover additional targeted drug therapies and the least toxic doses of those therapies that are most effective in curing the individual, whether canine or human.